PharmaKB logo
Company Reports
Company Reports
Drug Reports
Drug Reports
Disease Reports
Disease Reports
Sets
Sets
Favorites
Favorites
Log in
Log in
AboutPricing
Company ReportsAdams Respiratory Therapeutics
Adams Respiratory Therapeutics(ARXT)
Download report
Favorite
Financial
Marketed Drugs
Clinical Trials
Financial
Stock price
*Currency in USD
Loading
Company Revenue
No data
Revenue by Drug
Loading
Marketed Drugs
No data
Clinical Trials
Therapeutic Areas:
All
Classification:
All
Approval:
All
Status:
All
Phases:
All
Drug Name
Phase 1
Phase 2
Phase 3
Phase 4
Indication
Erdosteine
infections
,
hiv infections
,
acquired immunodeficiency syndrome
,
communicable diseases
Lotamilast
chronic obstructive pulmonary disease
,
sleep wake disorders
,
alcoholism
,
addictive behavior
,
huntington disease
,
healthy volunteers/patients
,
neoplasms
,
hypoxia
,
anxiety disorders
,
major depressive disorder
,
depressive disorder
,
pain
,
gastroparesis
,
type 2 diabetes mellitus
,
sleep initiation and maintenance disorders
,
obesity
,
dyslipidemias
,
cholestasis
,
pruritus
,
biliary liver cirrhosis
,
diabetes mellitus
,
critical illness
,
intrahepatic cholestasis
,
subarachnoid hemorrhage
,
intracranial vasospasm
,
body weight
,
back pain
,
hypercholesterolemia
,
inflammation
Remetinostat
gastrointestinal motility
,
critical illness
Tiratricol
respiratory tract infections
,
common cold
Usistapide
gastrointestinal motility
,
critical illness
© 2020-2025 Collaborative Drug Discovery Inc. (CDD) | Terms of Use